Barretts Esophagus With Dysplasia Clinical Trial
— PatheBarettOfficial title:
Impact of Histologic Concordance Between Biopsies and the Endoscopic Resection Specimen, in the Treatment of Barrett's Esophagus in Dysplasia, on the Recurrence of Dysplasia
NCT number | NCT03685799 |
Other study ID # | PatheBarett-IPC 2016-005 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | May 2016 |
Est. completion date | June 2016 |
Verified date | September 2018 |
Source | Institut Paoli-Calmettes |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Influence of histological concordance on the risk of recurrence:
the histological concordance being the comparison between the biopsies and the endoscopic
resection piece and its concordant response rate.
Status | Completed |
Enrollment | 18 |
Est. completion date | June 2016 |
Est. primary completion date | June 2016 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - patients with DHG on Barrett's esophagus on endoscopic biopsies followed by endoscopic resection. Exclusion Criteria: |
Country | Name | City | State |
---|---|---|---|
France | Institut Paoli-Calmettes | Marseille | Bouches-du Rhône |
Lead Sponsor | Collaborator |
---|---|
Institut Paoli-Calmettes |
France,
Godat S, Caillol F, Autret A, Bories E, Pesenti C, Ratone JP, De Cassan C, Poizat F, Giovannini M. Endotherapy in case of relapse of neoplastic Barrett's esophagus after successful initial endoscopic resection. Surg Endosc. 2017 Sep;31(9):3703-3710. doi: — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Influence of histological concordance on the risk of recurrence | the histological concordance being the comparison between the biopsies and the endoscopic resection piece and its concordant response rate. | 1 day | |
Secondary | Identification of histological factors of recurrence. | Identification of histological factors of recurrence. | 1 day |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05530343 -
Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance
|
N/A | |
Recruiting |
NCT06071845 -
Assessment of a Minimally Invasive Collection Device for Molecular Analysis of Esophageal Samples
|
N/A | |
Recruiting |
NCT04001478 -
Non-invasive Testing for Early oEesophageal Cancer and Dysplasia
|
||
Recruiting |
NCT04295811 -
Efficacy of EsoGuard Assay on Esophageal Surface Cells Collected With EsoCheck vs EGD for the Diagnosis of BE or EAC
|
N/A | |
Not yet recruiting |
NCT04843397 -
Diagnostic Performance Indicators in Upper GI Endoscopy:PROSPERO Study
|
||
Completed |
NCT03120195 -
EndoRotor® Ablation of Barrett's Esophagus: Safety and Feasibility Study
|
N/A | |
Recruiting |
NCT05753748 -
Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia
|
N/A | |
Enrolling by invitation |
NCT04561791 -
Evaluation of Tethered Capsule Endomicroscopy as a Screening Tool for Barrett's Esophagus in the Primary Care Setting
|
N/A | |
Completed |
NCT04293458 -
Efficacy of EsoGuard on Samples Collected Using EsoCheck Versus EGD for the Diagnosis of BE
|
N/A | |
Recruiting |
NCT06030180 -
CLUE: CLinical Utility Study of EsoGuard
|
N/A | |
Active, not recruiting |
NCT02994693 -
Natural History of Barrett's Esophagus Using Tethered Capsule Endomicroscopy
|
||
Not yet recruiting |
NCT05276791 -
EMR Versus ESD for Barrett's Neoplasia
|
N/A | |
Completed |
NCT03193216 -
The Impact of Adjuvant Liquid Alginate on Endoscopic Ablation Therapy of Complicated Barrett's Esophagus
|
Phase 2 | |
Recruiting |
NCT05983419 -
Complete Resection of Barrett's Esophagus Harboring Neoplasia With Endoscopic Submucosal Dissection.
|
N/A | |
Completed |
NCT06381583 -
A Liquid Biopsy for High-risk Pre-cancer Screening of Esophageal Adenocarcinoma
|
||
Recruiting |
NCT05965999 -
Lucid Registry Study
|
||
Completed |
NCT04316975 -
Utility Of Mutational Load As A Predictor For Endoscopic Treatment Response In Barrett's Esophagus
|
N/A |